Marksans Pharma standalone net profit rises 17.30% in the September 2021 quarter

Sales rise 22.76% to Rs 168.85 crore

Net profit of Marksans Pharma rose 17.30% to Rs 27.60 crore in the quarter ended September 2021 as against Rs 23.53 crore during the previous quarter ended September 2020. Sales rose 22.76% to Rs 168.85 crore in the quarter ended September 2021 as against Rs 137.55 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales168.85137.55 23 OPM %20.0916.75 -PBDT41.3234.68 19 PBT37.0231.01 19 NP27.6023.53 17

Powered by Capital Market - Live News